Diligence memo · auto-generated · as of July 2, 2026

Xtant Medical Holdings, Inc.

Xtant Medical Holdings, Inc. looks under-valued against its niche peers and is quiet on financing cadence.

SourceModeled below same-niche peers while still financing on rhythm — a potential mispricing worth a closer look.

Businessfiled

Xtant Medical Holdings, Inc. operates in Healthtech, based in BELGRADE.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Xtant Medical Holdings, Inc. has raised $170M in disclosed capital across 9 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).

Largest single filing: $63M on 2020-10-01.

Most recent recorded round closed around 2024-08-09.

Valuation (modeled)modeled

Provath models Xtant Medical Holdings, Inc. at approximately $41M (range $18M–$62M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.08× the median modeled value of Series C Healthtech companies in 2022–2024 (39 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 19 months.

Last raise 23 mo ago; this sector typically re-raises about every 14 months.

Slightly overdue versus sector cadence.

The last round was 3.0× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 98% of Healthtech peers (2138 compared).

Modeled value ranks above 59% of those peers.

Closest niche peers: Freedom Dental Funding, LLC, Elevate Care International Topco LP, Athelas Inc., Hazel Health, Inc., Health Gorilla, Inc..

Peoplefiled

24 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.